CytoMed Therapeutics Ltd (GDTC) reporting calendar
CytoMed Therapeutics Ltd files periodic reports with the SEC as GDTC on Nasdaq. Atlas tracks 4 filed reports for this issuer, each linked to its original EDGAR accession.
- Latest report
- 20-F
- Period ended
- 31 Dec 2025
- Filed
- 31 Mar 2026
- Reports on record
- 4
Open GDTC market profile
Latest filing on SEC EDGAR ↗
Pharmaceutical Preparations reporting datesAll Nasdaq reporting dates
Filed periodic reports
| Form | Period ended | Filed | Lag | SEC accession |
|---|---|---|---|---|
| 20-F | 31 Dec 2025 | 31 Mar 2026 | 90 days | 0001493152-26-013813 |
| 20-F | 31 Dec 2024 | 28 Apr 2025 | 118 days | 0001641172-25-006458 |
| 20-F | 31 Dec 2023 | 22 Apr 2024 | 113 days | 0001493152-24-015594 |
| 20-F | 31 Dec 2022 | 1 May 2023 | 121 days | 0001493152-23-015042 |
Source: SEC EDGAR company submissions for CIK 0001873093. Atlas publishes filed facts only. The SEC does not publish forward reporting dates, so no announced future date is claimed here.